- Home
- RAPT vs ORGN Comparison
RAPT vs ORGN Comparison
Compare RAPT & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- ORGN
- Stock Information
- Founded
- RAPT 2015
- ORGN 2008
- Country
- RAPT United States
- ORGN United States
- Employees
- RAPT N/A
- ORGN N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- ORGN Major Chemicals
- Sector
- RAPT Health Care
- ORGN Industrials
- Exchange
- RAPT Nasdaq
- ORGN Nasdaq
- Market Cap
- RAPT 122.9M
- ORGN 131.4M
- IPO Year
- RAPT 2019
- ORGN N/A
- Fundamental
- Price
- RAPT $11.74
- ORGN $0.56
- Analyst Decision
- RAPT Buy
- ORGN Strong Buy
- Analyst Count
- RAPT 5
- ORGN 1
- Target Price
- RAPT $33.60
- ORGN $3.00
- AVG Volume (30 Days)
- RAPT 105.9K
- ORGN 1.9M
- Earning Date
- RAPT 08-07-2025
- ORGN 08-14-2025
- Dividend Yield
- RAPT N/A
- ORGN N/A
- EPS Growth
- RAPT N/A
- ORGN N/A
- EPS
- RAPT N/A
- ORGN N/A
- Revenue
- RAPT N/A
- ORGN $28,667,000.00
- Revenue This Year
- RAPT N/A
- ORGN $49.18
- Revenue Next Year
- RAPT N/A
- ORGN $144.81
- P/E Ratio
- RAPT N/A
- ORGN N/A
- Revenue Growth
- RAPT N/A
- ORGN N/A
- 52 Week Low
- RAPT $5.67
- ORGN $0.40
- 52 Week High
- RAPT $26.56
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- RAPT 58.44
- ORGN 38.09
- Support Level
- RAPT $10.20
- ORGN $0.66
- Resistance Level
- RAPT $13.50
- ORGN $0.95
- Average True Range (ATR)
- RAPT 1.01
- ORGN 0.09
- MACD
- RAPT -0.05
- ORGN -0.02
- Stochastic Oscillator
- RAPT 77.46
- ORGN 2.47
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.